Canlyniadau Chwilio - Leif Klint

  • Dangos 1 - 2 canlyniadau o 2
Mireinio'r Canlyniadau
  1. 1
  2. 2

    Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) gan Thomas Bachelot, Eva Ciruelos, Andreas Schneeweiß, Fabio Puglisi, Tamar Peretz‐Yablonski, Igor Bondarenko, Shani Paluch‐Shimon, Andrew Wardley, Jean-Louis Merot, Yolande Du Toit, V. Easton, Nicolas Lindegger, David Miles, Kamel Bouzid, Mario Campone, Bruno Coudert, Zbigniew Nowecki, Hassan Errihani, Florence Dalenc, Ana Ferreira, Max S. Mano, Francesco Ricci, Haralabos P. Kalofonos, Claudia Andreetta, Filippo Montemurro, Sophie Barrett, Qingyuan Zhang, Dimitris Mavroudis, Juan Antonio Matus, Carlos Beato, Xichun Hu, Rabab Gaafar, Hamdy Abdel Azeem, Christophe Perrin, Johannes Ettl, István Láng, Sunil Verma, Huiping Li, Étienne Brain, Oliver Hoffmann, Anna Cariello, Carlo Tondini, Taher Altwegeiri, Niklas Loman, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, Fernando Palacios Salas, Joanna Streb, A Wroński, Salomón Menjón Beltrán, İrfan Çiçin, Peter Schmid, Robert Laing, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Luca Gianni, Giuseppe Curigliano, Alejandro Juarez, Snežana Šušnjar, Erika Matos, Rüçhan Uslu, Hans Wildiers, Marcelo Cruz, Hugues Bourgeois, Raquel von Schumann, Salomon M. Stemmer, Flavia Morales Vásquez, Adriana Domínguez, Marek Z. Wojtukiewicz, Jasna Trifunović, José Juan Illarramendi, Laura García, Y. Izarzugaza Perón, María José Echarri, Natliia Voitko, Duncan Wheatley, Simon Waters, Richard de Boer, Guy Jérusalem, Véronique Cocquyt, Carlos H. Barrios, Lawrence Panasci, Johanna Mattson, Minna Tanner, M. Gozy, G. Vasilopoulos, János Révész, Luciano Latini, Cesare Gridelli, Jesus Miguel Lazaro, Antonio González, A. Barnadas Molins, Eduardo Martínez de Dueñas, Jesús Alarcón, Ana Arance, Leif Klint, Oleksiy Kovalyov, Richard D. Baird

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo